EB
Emily Bodnar HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
85
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.3%
Neutral
18.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $7 |
126%
upside
| 1 | +19% |
0
%
| 4 Mar ‘26 2 days ago |
|
|
|
Buy
Maintained
| $66 |
17%
upside
| 1 | +20% |
0
%
| 4 Mar ‘26 2 days ago |
|
|
|
Buy
Reiterated
| $32 |
46%
upside
| 2 | +5.1% |
0
%
| 2 Mar ‘26 4 days ago |
|
|
|
Buy
Maintained
| $49 |
268%
upside
| 3 | +2.8% |
0
%
| 26 Feb ‘26 8 days ago |
|
|
|
Neutral
Downgraded
| $115 |
0%
upside
| 2 | -1.2% |
0
%
| 23 Feb ‘26 11 days ago |
|
|
|
Buy
Initiated
| $9 |
496%
upside
| 1 | +7.9% |
0
%
| 17 Feb ‘26 17 days ago |
|
|
|
Buy
Maintained
| $65 |
140%
upside
| 2 | -6.2% |
0
%
| 12 Feb ‘26 22 days ago |
|
|
|
Neutral
Downgraded
| $58 | – | 1 | +96% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $14 | – | 1 | +70% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $47 |
30%
upside
| 1 | +45% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $45 |
108%
upside
| 1 | +54% |
0
%
| 11 Dec ‘25 2 months ago |
|